Health and wellness influencers are hawking unapproved treatments on the gray market. The future of the F.D.A.—and the health ...

AI has scaled content production, but not trust. Here’s how marketers can close the gap with strategy, storytelling, and ...

After the death of his brother, David, Eddie Brigati opens his "Rascal Barn" and shares memories of their glory days with the ...

Every weekday, the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap ...

Matthew Gallagher launched Medvi, a GLP-1 telehealth company, from his Los Angeles home in September 2024. Fourteen months ...

Hapag-Lloyd voiced cautious optimism on Wednesday on the prospect of resuming shipping through the Strait of Hormuz after a ...

Market strategist Gareth Soloway dissects oil's impact on equities, S&P 500 targets, Russell 2000 risks, de-dollarization, ...

Andres Rincon says fund flows indicate investors are looking to commodity and defensive ETFs for protection and ...

Experience the mesmerizing transformation of eight unique plants over 1,020 days in this stunning time-lapse compilation.

Cheryl Miller and other women’s basketball trailblazers, including Big East Commissioner Val Ackerman and former UCLA ...

REITs look undervalued: explore data center, industrial & net-lease picks (Equinix, Prologis, Realty Income) for reliable ...

A primary area of interest at the AACR congress will be the drug candidate SLS009. Sellas recently enrolled the first patient into a Phase 2 clinical trial investigating this therapy for acute myeloid ...